Featured Articles

41. Mechanical Movement EVokes Increase In Extracellular Vesicle Production 8/17/2022

    We demonstrate a 12-layer cell culture vessel can be used to produce seven trillion high quality EVs from mesenchymal stem cells (MSCs).

42. A Novel Approach To Type 1 Diabetes Treatment 8/2/2022

    With the combination of a viral vector platform and a fixed bed bioreactor platform, a lab is working on a curative gene therapy that could address and possibly reverse T1D's underlying mechanisms.

43. From Bench To Billions: Facilitating Scale-Up Of Adherent Cultures For Cell And Gene Therapies 6/27/2022

    We review what researchers should consider when they are creating a risk-mitigating adherent culture process for cell and gene therapy scale-up.

44. Comparing Gene Transfer Tools: Adeno-Associated Virus And Lentiviral Vectors 6/8/2022

    We review the advantages, disadvantages, and scaling considerations of adeno-associated virus (AAV) and lentivirus (LV) vector gene transfer mechanisms.

45. Cell Suspension Or Adherent Cell Surface: Which Method Is Right For Your Lab? 6/8/2022

    We review what to consider when selecting an adherent or a suspension platform for your cell culture method to achieve the best growing conditions.

46. Exploring What's Possible With Stem Cell Therapies 6/8/2022

    Explore the changing landscape of stem cell research and cell therapy production and read how emerging solutions have facilitated a new era of more effective and efficient workflows.

47. Why Are MSC-EVs Important And How Can You Scale-Up? 5/26/2022

    Read how with more efficient and consistent production methods, researchers will be able to maximize the full potential of EVs for research and therapeutic application.

48. Large Scale Transient Transfection For Lentiviral Vector Production 3/24/2022

    We employed the Corning HYPERStack cell culture vessel with our High Yield PERformance (HYPER) technology to reduce the air space within the vessel and achieve a higher yield per volume of space.

49. Adipose-derived Human Mesenchymal Cell Production 3/24/2022

    We review a solution for scaling up large quantities of highly viable adipose-derived MSCs expressing the ISCT defined criteria for hMSC quality to meet those growing demands.

50. Lessons Learned: An Inside Look At Overcoming Stem Cell Therapy Scale-up 3/10/2022

    Dr. Carolyn Wrightson shares some of the valuable lessons and considerations she and her team learned about stem cell therapy scale-up and optimization.